Indexed keywords
2 ARACHIDONOYLGLYCEROL;
ANANDAMIDE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CYCLIC AMP;
LIPOXIN A;
ANTIINFLAMMATORY AGENT;
LIPOXIN;
BINDING SITE;
CATALEPSY;
CATALYSIS;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
XENOPUS LAEVIS;
ANIMAL;
METABOLISM;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
LIPOXINS;
RECEPTOR, CANNABINOID, CB1;
1
18444376760
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
Howlett AC, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54(2):161-202.
(2002)
Pharmacol Rev , vol.54
, Issue.2
, pp. 161-202
Howlett, A.C.1
2
33644804271
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
Pertwee RG (2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J 7(3):E625-E654.
(2005)
AAPS J , vol.7
, Issue.3
Pertwee, R.G.1
3
43249100162
Targeting the endocannabinoid system: To enhance or reduce?
Di Marzo V (2008) Targeting the endocannabinoid system: To enhance or reduce? Nat Rev Drug Discov 7(5):438-455.
(2008)
Nat Rev Drug Discov , vol.7
, Issue.5
, pp. 438-455
Di Marzo, V.1
4
78650115271
Positive allosteric modulators of CB1 receptors
International Cannabinoid Research Society, Burlington, VT
Adam L, et al. (2007) Positive allosteric modulators of CB1 receptors. 17th Annual Symposium on the Cannabinoids (International Cannabinoid Research Society, Burlington, VT), p 86.
(2007)
17th Annual Symposium on the Cannabinoids , pp. 86
Adam, L.1
5
35648985647
1 receptors with hypophagic effects in rats
1 receptors with hypophagic effects in rats. Br J Pharmacol 152(5):805-814.
(2007)
Br J Pharmacol , vol.152
, Issue.5
, pp. 805-814
Horswill, J.G.1
6
24044539957
1 receptor
1 receptor. Mol Pharmacol 68(5):1484-1495.
(2005)
Mol Pharmacol , vol.68
, Issue.5
, pp. 1484-1495
Price, M.R.1
7
35648962852
1 receptors: The shape of things to come
1 receptors: The shape of things to come. Trends Pharmacol Sci 28(11):567-572.
(2007)
Trends Pharmacol Sci , vol.28
, Issue.11
, pp. 567-572
Ross, R.A.1
8
0027078685
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Devane WA, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090):1946-1949.
(1992)
Science , vol.258
, Issue.5090
, pp. 1946-1949
Devane, W.A.1
10
81355156238
Guide to receptors and channels (GRAC), 5th edition
Alexander SPH, Mathie A, Peters JA (2011) Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164(suppl 1):S1-S324.
(2011)
Br J Pharmacol , vol.164
, Issue.SUPPL. 1
Alexander, S.P.H.1
Mathie, A.2
Peters, J.A.3
11
82655181504
4 is a novel estrogen receptor modulator
4 is a novel estrogen receptor modulator. FASEB J 25(12):4326-4337.
(2011)
FASEB J , vol.25
, Issue.12
, pp. 4326-4337
Russell, R.1
12
67649438808
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family
Ye RD, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61(2):119-161.
(2009)
Pharmacol Rev , vol.61
, Issue.2
, pp. 119-161
Ye, R.D.1
13
0036258990
G protein-coupled receptor allosterism and complexing
Christopoulos A, Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54(2):323-374.
(2002)
Pharmacol Rev , vol.54
, Issue.2
, pp. 323-374
Christopoulos, A.1
Kenakin, T.2
